These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29049986)

  • 21. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
    Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
    Bhide P; Dilgil M; Gudi A; Shah A; Akwaa C; Homburg R
    Fertil Steril; 2015 Feb; 103(2):537-41. PubMed ID: 25467043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals.
    Caanen MR; Schouten NE; Kuijper EAM; van Rijswijk J; van den Berg MH; van Dulmen-den Broeder E; Overbeek A; van Leeuwen FE; van Trotsenburg M; Lambalk CB
    Hum Reprod; 2017 Jul; 32(7):1457-1464. PubMed ID: 28505246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the presence of polycystic ovary syndrome-related features on anti-Mullerian hormone and androstenedione levels in adolescents with or without menstrual irregularity.
    Hanedan N; Ersoy B; Hanedan C; Ozyurt BC; Taneli F
    Arch Gynecol Obstet; 2022 Aug; 306(2):523-531. PubMed ID: 35355114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of Polycystic Ovary Syndrome: AMH in combination with clinical symptoms.
    Sahmay S; Aydin Y; Oncul M; Senturk LM
    J Assist Reprod Genet; 2014 Feb; 31(2):213-20. PubMed ID: 24343036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic criteria for PCOS: Is there a need for a rethink?
    Dewailly D
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():5-11. PubMed ID: 27151631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycystic Ovarian Morphology in Normocyclic Non-hyperandrogenic Adolescents.
    Fulghesu AM; Canu E; Casula L; Melis F; Gambineri A
    J Pediatr Adolesc Gynecol; 2021 Oct; 34(5):610-616. PubMed ID: 33571658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DIAGNOSTIC VALUE OF ANTI-MÜLLERIAN HORMONE AS A BIOMARKER FOR POLYCYSTIC OVARY SYNDROME: A META-ANALYSIS UPDATE.
    Zhao Y; Zhao Y; Wang C; Liang Z; Liu X
    Endocr Pract; 2019 Oct; 25(10):1056-1066. PubMed ID: 31414908
    [No Abstract]   [Full Text] [Related]  

  • 29. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
    Adams JM; Taylor AE; Crowley WF; Hall JE
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of ultrasound in the diagnosis of polycystic ovary syndrome in adolescents.
    Youngster M; Ward VL; Blood EA; Barnewolt CE; Emans SJ; Divasta AD
    Fertil Steril; 2014 Nov; 102(5):1432-8. PubMed ID: 25226858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus.
    Codner E; Soto N; Lopez P; Trejo L; Avila A; Eyzaguirre FC; Iniguez G; Cassorla F
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2250-6. PubMed ID: 16569737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
    Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
    Bradbury RA; Lee P; Smith HC
    Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revised criteria for PCOS in WHO Group II anovulatory infertility - a revival of hypothalamic amenorrhoea?
    Lauritsen MP; Pinborg A; Loft A; Petersen JH; Mikkelsen AL; Bjerge MR; Nyboe Andersen A
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):584-91. PubMed ID: 25262871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.
    Rosenfield RL
    J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):412-9. PubMed ID: 25840648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome.
    Murphy MK; Hall JE; Adams JM; Lee H; Welt CK
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3878-84. PubMed ID: 16882750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic characteristics and metabolic risk factors of cases with polycystic ovary syndrome during adolescence.
    Sıklar Z; Berberoğlu M; Çamtosun E; Kocaay P
    J Pediatr Adolesc Gynecol; 2015 Apr; 28(2):78-83. PubMed ID: 25850587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
    Dewailly D; Pigny P; Soudan B; Catteau-Jonard S; Decanter C; Poncelet E; Duhamel A
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features.
    Welt CK; Gudmundsson JA; Arason G; Adams J; Palsdottir H; Gudlaugsdottir G; Ingadottir G; Crowley WF
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4842-8. PubMed ID: 17003085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome.
    Matsuzaki T; Munkhzaya M; Iwasa T; Tungalagsuvd A; Yano K; Mayila Y; Yanagihara R; Tokui T; Kato T; Kuwahara A; Matsui S; Irahara M
    Endocr J; 2017 May; 64(5):531-541. PubMed ID: 28381699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.